Published by Iain Gilbert on 4th November 2022
(Sharecast News) - Drugmaker AstraZeneca said on Friday that its Beyfortus asset had received European Union approval for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants.
URL: http://www.digitallook.com/dl/news/story/33085227/...